Blog

Tackling Covid-19 Vaccine Hesitancy in Limited English Proficient Communities: Lessons From the Flu Shot.

2020 was an unprecedented year of innovation in healthcare. The Covid-19 pandemic led to numerous scientific advances in diagnostics, treatments and vaccines to combat the SARS-CoV2 coronavirus. But developing vaccines is just one part of the effort to end the pandemic, encouraging people to take them is another challenge. Previous widespread vaccination campaigns, such as […]

Why Linguistic Validation is Crucial To Ensuring eCOA is Culturally and Conceptually Equivalent

Over the last 20 years, the worldwide number of clinical trials has increased exponentially. Clinical trials also become more complex, with the adoption of multi-center, international interventions becoming the norm. This means that the pharmaceutical industry is confronted with the exponential growth in costs associated with running such clinical trials, with each molecule requiring approximately […]

Driving Diversity in Clinical Trials

A recent article published by Clinical Leader illustrates the importance of making information about clinical trial participation accessible to those who are currently under-represented in pharmaceutical research. The findings concluded that understanding where minority groups are currently going to find further information is a good start to bridging the existing disparities in Clinical Research by […]